Detalles del proyecto
Descripción
COVID-19 pandemic has affected more than 80 million people around the globe. The epidemic has evolved at different speeds and times worldwide. Thus, describing the patients and the treatments used in countries where the epidemic began (e.g., China, Italy, UK) have helped other countries to prepare before COVID-19 arrival at their own countries. Thus, observational registries and the evidence they generate are of vital importance for decision-makers, patients, and physicians around the world. As with other pulmonary infections, patients with COVID-19 may develop systemic complications (e.g., heart failure, pulmonary embolisms, among others), which can worsen clinical outcomes. The ISARIC-COVID-19 dataset is the world’s largest standardized collection of comprehensive clinical data. Importantly, this dataset is freely available, which opens the possibility for any research to address knowledge gaps. This project will produce documentation, code and pre-processing of that dataset to accelerate and optimise its use. This dataset is a rich tool for characterizing the systemic complications contributing to the morbidity and mortality of COVID-19. As data identifying the risk factor and clinical characteristics of these complications are scarce, we hypothesize that creating a detailed data descriptor manuscript, a reference tutorial-like code, and using the systemic complications analysis as an example, would allow researchers without advanced coding skills to fully utilize the ISARIC-COVID-19 dataset.Finally, ensuring the dataset is correctly used and that researchers can make the best out of this dataset will improve the understating of the COVID-19 and its systemic complications.
Descripción de Layman
COVID-19 pandemic has affected more than 80 million people around the globe. The epidemic has evolved at different speeds and times worldwide. Thus, describing the patients and the treatments used in countries where the epidemic began (e.g., China, Italy, UK) have helped other countries to prepare before COVID-19 arrival at their own countries. Thus, observational registries and the evidence they generate are of vital importance for decision-makers, patients, and physicians around the world. As with other pulmonary infections, patients with COVID-19 may develop systemic complications (e.g., heart failure, pulmonary embolisms, among others), which can worsen clinical outcomes. The ISARIC-COVID-19 dataset is the world’s largest standardized collection of comprehensive clinical data. Importantly, this dataset is freely available, which opens the possibility for any research to address knowledge gaps. This project will produce documentation, code and pre-processing of that dataset to accelerate and optimise its use. This dataset is a rich tool for characterizing the systemic complications contributing to the morbidity and mortality of COVID-19. As data identifying the risk factor and clinical characteristics of these complications are scarce, we hypothesize that creating a detailed data descriptor manuscript, a reference tutorial-like code, and using the systemic complications analysis as an example, would allow researchers without advanced coding skills to fully utilize the ISARIC-COVID-19 dataset.Finally, ensuring the dataset is correctly used and that researchers can make the best out of this dataset will improve the understating of the COVID-19 and its systemic complications.
Hallazgos clave
COVID 19, risk factors,
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 5/07/21 → 5/07/22 |
Socios colaboradores
- Universidad de La Sabana (principal)
- University of Oxford (Co-ejecutor)
- Network Improving Critical Care Systems and Training (Co-ejecutor)
- BC Children’s Hospital (Co-ejecutor)
- Bill & Melinda Gates Foundation (CoFinanciador)
Estado del Proyecto
- Cerrado exitosamente
Relación academia-corporación
- No
Formación de recurso humano para la investigación
- No
Interdisciplinar
- No
Proyecto colaborativo entre grupos de investigación
- No
Proyecto con potencial de desarrollo tecnológico susceptible de protección con propiedad intelectual
- No
Trabajo de grado - Maestría o Doctorado
- Ninguno
Área del conocimiento (OCDE)
- MEDICINA - CIENCIAS CLINICAS
Rol Sabana
- Ejecutora
Huella digital
Explore los temas de investigación que se abordan en este proyecto. Estas etiquetas se generan con base en las adjudicaciones/concesiones subyacentes. Juntos, forma una huella digital única.
Producción científica
- 6 Artículo
-
Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves exposure-stratified prospective cohort study in Moscow (StopCOVID)
Pazukhina, E., Rumyantsev, M., Baimukhambetova, D., Bondarenko, E., Markina, N., El-Taravi, Y., Petrova, P., Ezhova, A., Andreeva, M., Iakovleva, E., Bobkova, P., Pikuza, M., Trefilova, A., Abdeeva, E., Galiautdinova, A., Filippova, Y., Bairashevskaia, A., Zolotarev, A., Bulanov, N. & DunnGalvin, A. y 30 otros, , dic. 2024, En: BMC Medicine. 22, 1, 48.Producción científica: Contribución a una revista › Artículo › revisión exhaustiva
Acceso abierto12 Citas (Scopus) -
Sex differences in post-acute neurological sequelae of SARS-CoV-2 and symptom resolution in adults after coronavirus disease 2019 hospitalization: an international multi-centre prospective observational study
ISARIC Clinical Characterisation Group & Reyes, L. F., 1 mar. 2024, En: Brain Communications. 6, 2, p. 1-14 14 p., fcae036.Producción científica: Contribución a una revista › Artículo › revisión exhaustiva
9 Citas (Scopus) -
Effectiveness of prolonged versus standard-course of oseltamivir in critically ill patients with severe influenza infection: A multicentre cohort study
Reyes Velasco, L. F. (Otro Numero de Autor), Diaz, E. (Otro Numero de Autor), Moreno, G. (Otro Numero de Autor), Restrepo, M. I. (Otro Numero de Autor) & Martin-Loeches,, I. (Otro Numero de Autor), 3 ago. 2023, En: Journal of Medical Virology. p. 1-13 12 p.Título traducido de la contribución :Effectiveness of prolonged versus standard-course of oseltamivir in critically ill patients with severe influenza infection: A multicentre cohort study Producción científica: Contribución a una revista › Artículo › revisión exhaustiva
12 Citas (Scopus)